DGS Capital Management LLC bought a new position in SIGA Technologies, Inc. (NASDAQ:SIGA – Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 24,404 shares of the company’s stock, valued at approximately $165,000.
A number of other hedge funds and other institutional investors also recently bought and sold shares of the stock. AltraVue Capital LLC grew its position in shares of SIGA Technologies by 6.6% during the second quarter. AltraVue Capital LLC now owns 2,177,646 shares of the company’s stock worth $16,528,000 after acquiring an additional 134,450 shares during the last quarter. Hotchkis & Wiley Capital Management LLC boosted its stake in SIGA Technologies by 152.6% during the 3rd quarter. Hotchkis & Wiley Capital Management LLC now owns 2,048,440 shares of the company’s stock valued at $13,827,000 after purchasing an additional 1,237,620 shares during the period. Dimensional Fund Advisors LP grew its position in SIGA Technologies by 7.9% in the 2nd quarter. Dimensional Fund Advisors LP now owns 1,821,788 shares of the company’s stock worth $13,826,000 after purchasing an additional 133,883 shares during the last quarter. Geode Capital Management LLC increased its stake in shares of SIGA Technologies by 6.3% in the third quarter. Geode Capital Management LLC now owns 1,112,743 shares of the company’s stock valued at $7,512,000 after purchasing an additional 66,344 shares during the period. Finally, American Century Companies Inc. raised its holdings in shares of SIGA Technologies by 251.2% during the second quarter. American Century Companies Inc. now owns 841,759 shares of the company’s stock valued at $6,389,000 after buying an additional 602,091 shares during the last quarter. 55.40% of the stock is currently owned by institutional investors and hedge funds.
SIGA Technologies Price Performance
Shares of SIGA stock opened at $6.18 on Friday. SIGA Technologies, Inc. has a 12-month low of $4.26 and a 12-month high of $12.83. The firm has a market capitalization of $441.28 million, a price-to-earnings ratio of 5.15 and a beta of 0.89. The business has a 50 day simple moving average of $6.83 and a 200 day simple moving average of $7.78.
About SIGA Technologies
SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.
See Also
- Five stocks we like better than SIGA Technologies
- With Risk Tolerance, One Size Does Not Fit All
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Texas Instruments: The Old-School Tech Titan Still Delivering
- What is Short Interest? How to Use It
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Want to see what other hedge funds are holding SIGA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SIGA Technologies, Inc. (NASDAQ:SIGA – Free Report).
Receive News & Ratings for SIGA Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SIGA Technologies and related companies with MarketBeat.com's FREE daily email newsletter.